Cholesterol and Coronary Heart Disease: New Data from the Woscop Study

Author： Poli A.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.35, Iss.3, 1997-03, pp. : 171-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesterol-Lowering Drugs for Primary Prevention? The Woscop Study

By Muntoni S.  

Pharmacological Research, Vol. 35, Iss. 3, 1997-03 ,pp. : 169-170

Academic Press

Access to resources Recommend Favorite

The A-SACT (Achievement in Singapore of Cholesterol Targets) Study in Patients with Coronary Heart Disease

By Ho Kheng-Thye  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 383-391

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease: Evaluative Study Carried Out in Spain

By Plans-Rubió P.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 623-643

Adis International

Access to resources Recommend Favorite

New Surrogate Markers for Coronary Heart Disease

By  

Heart Drug, Vol. 1, Iss. 5, 2002-01 ,pp. : 242-243

Karger

Access to resources Recommend Favorite

Cholesterol and Coronary Disease—The Altered Landscape

By LaRosa John  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 9-10

Springer Publishing Company

Access to resources Recommend Favorite